MedTrace Logo

Testing Mestinon and Exercise in Fibromyalgia

NCT00535587 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 178

Last updated 2011-04-18

Study results available
· View outcomes & findings →

Summary

The purpose of this trial was to test the combined and independent effects of 6 months of exercise and Mestinon in people with fibromyalgia. Specifically, we wanted to determine if Mestinon helped people with fibromyalgia have an easier time exercising and if their symptoms improved by the end of the trial.

Conditions

  • Fibromyalgia

Interventions

BEHAVIORAL

Exercise

DRUG

pyridostigmine

DRUG

Placibo

BEHAVIORAL

Attention Control

Sponsors & Collaborators

  • National Institute of Nursing Research (NINR)

    collaborator NIH

  • Oregon Health and Science University

    lead OTHER

Principal Investigators

  • Edit Serfozo, MPH · Oregon Health and Science University

  • Kim Dupree Jones, PhD · Oregon Health and Science University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-09-30
Primary Completion
2008-06-30
Completion
2008-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00535587 on ClinicalTrials.gov